Related Experiment Video
Updated: Sep 28, 2026

Isolation and Functional Characterization of Human Ventricular Cardiomyocytes from Fresh Surgical Samples
Published on: April 21, 2014
Alterations in apoptotic signaling in human idiopathic cardiomyopathic hearts in failure
Charles Steenbergen1, Cynthia A Afshari, John G Petranka
1Department of Pathology, Duke University Medical Center, Durham 27710, USA.
Insights
This study investigated gene expression in human hearts with dilated cardiomyopathy and heart failure. Researchers found a shift towards apoptosis, with decreased expression of key anti-apoptotic genes, suggesting new therapeutic targets.
Area of Science:
- Cardiovascular Biology
- Molecular Medicine
- Genomics
Background:
- Dilated cardiomyopathy (DCM) is a heart failure cause with unknown origins.
- Altered gene expression is implicated in heart failure progression, but human data is limited.
- Apoptosis plays a role in heart failure pathogenesis.
Purpose of the Study:
- To investigate changes in apoptosis-related gene expression in human idiopathic DCM hearts with heart failure.
- To identify specific molecular pathways altered in human heart failure.
- To uncover potential therapeutic targets for DCM and heart failure.
Main Methods:
- DNA microarray profiling of human idiopathic dilated cardiomyopathic hearts.
- Analysis of gene expression changes related to apoptosis.
- Investigation of the Tumor Necrosis Factor-alpha (TNF-alpha) signaling pathway.
Main Results:
- Observed a proapoptotic shift in the TNF-alpha signaling pathway.
- Found decreased expression of TNF-alpha- and Nuclear Factor-kappaB (NF-kappaB)-induced antiapoptotic genes, including growth arrest and DNA damage-inducible beta (GADD45beta), Flice inhibitory protein (FLIP), and TNF-induced protein 3 (A20).
- Observed decreased phosphorylation of BAD at Ser-112, consistent with increased apoptosis.
Conclusions:
- Human heart failure associated with DCM exhibits altered gene expression favoring apoptosis.
- The TNF-alpha signaling pathway is significantly impacted in failing human hearts.
- Identified specific genes and pathways as potential therapeutic targets for heart failure treatment.
Abstract:
Dilated cardiomyopathy, a disease of unknown etiology and pathogenesis, is associated with heart failure and compensatory hypertrophy. Although cell and animal models suggest a role for altered gene expression in the transition to heart failure, there is a paucity of data derived from the study of human heart tissue. In this study, we used DNA microarray profiling to investigate changes in the expression of genes involved in apoptosis that occur in human idiopathic dilated cardiomyopathic hearts that had progressed to heart failure. We observed altered gene expression consistent with a proapoptotic shift in the TNF-alpha signaling pathway. Specifically, we found decreased expression of TNF-alpha- and NF-kappaB-induced antiapoptotic genes such as growth arrest and DNA damage-inducible (GADD)45beta, Flice inhibitory protein (FLIP), and TNF-induced protein 3 (A20). Consistent with a role for apoptosis in heart failure, we also observed a significant decrease in phosphorylation of BAD at Ser-112. This study identifies several pathways that are altered in human heart failure and provides new targets for therapy.
Related Concept Videos
Heart Failure II: Pathophysiology
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Myocarditis I: Introduction
The Intrinsic Apoptotic Pathway

